DUBLIN – Top-line data from a placebo-controlled phase II trial of Vicore Pharma Holding AB’s angiotensin II type two receptor agonist, C21, provide preliminary evidence that the oral drug may provide benefit to patients with severe COVID-19 disease on top of steroid therapy.

LONDON – The Oxford University team behind the development of Astrazeneca plc’s COVID-19 vaccine have become the first to publish full and complete interim phase III data in a peer-reviewed journal.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amgen, Beigene, Cerecor, Cyxone, Henlius, ITM, Ix, Takeda, Turning Point.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alnylam, Astrazeneca, Athira, Betterlife, Boehringer Ingelheim, Bristol Myers Squibb, Centogene, Checkmate, Chinook, Ciloa, Citius, CN Pharm, Eyepoint, Genprex, Havn, Hyundai Bioscience, Inventiva, Kubota, Lineage Cell, Merck, Mannkind, Mind Cure, Neuraxpharm, Novecite, Pascal, Qrumpharma, Recce, Secarna, Soligenix, Sunshine, Theratechnologies, Transcend, Tris, Virpax, Xencor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aldeyra, Altimmune, Arena, Astrazeneca, Axsome, Bellus, Cardior, Curis, Domain, Harpoon, Larimar, Monopar, Novaliq, Panbela, Sojournix, Vicore, Xenon.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Advaite, Airehealth, Rheonix.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acutus Medical, Biotronik, Canary Health Technologies, DDF, Durect, Eurofins, Evonik, Seaspine, Sherlock Biosciences, Smartshape Design.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cerus, Precigen.